Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 29, 2014

View Archived Issues

The effect of bisphosphonate compounds in animal models of acute colitis

Recessive variant found in PCD deficiency with MODY-like diabetes

Invion updates on ongoing phase II trial of nadolol in mild asthma

Eutropics receives NCI contract to develop predictive tests for personalized AML treatment

Lipocine reports topline results from phase III trial of LPCN-1021

BerGenBio granted Wellcome Trust award for cancer development program

AstraZeneca discloses new FGFR-4 inhibitors

Reduced HYAL2 gene methylation in blood correlated with breast cancer

Safety and pharmacokinetics of ABT-767 in BRCA1 and BRCA2 germline tumors

FDA approves Vitekta

CHMP recommends approval of aclidinium bromide/formoterol fumarate

EMA recommends ketoconazole for approval in Cushing's syndrome

EMA committee recommends approval of Moventig

Roche divulges novel CB2 receptor agonists

Allergan discloses novel S1P1 receptor ligands

Roche discloses new agents for HCV infection

Genzyme presents promising data from 3-year follow up of CARE-MS I

New LRRK2 inhibitors disclosed by Merck & Co.

Application filed for marketing approval of remestemcel-L in Japan

Novartis applies for Japanese approval of panobinostat

EMA committee hands down positive opinion on Trulicity

FDA approves Iluvien for diabetic macular edema

Harvoni recommended for the treatment of chronic hepatitis C

EMA committee recommends European approval of Cyramza

Lixiana approved in Japan for additional indications

Signifor recommended by CHMP to treat patients with acromegaly

Boehringer Ingelheim's nintedanib receives positive opinion for second-line therapy of NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....